Amarin Corp Plc (AMRN)

[ziploc_1]

The article by TalShu on a new drug from Amarin, LR-EtEPA ...posted on August 2023(post# 414421) describes a potential successor to Vascepa...I hope we hear more in the near future about his new, improved, Amarin drug.

A short summary..."Based on 9 U.S. Provisional Patent Applications, Amarin has secured a worldwide patent priority claim to a lymph-releasing composition of eicosapentaenoic acid ethyl ester (LR-EtEPA) technology/invention and methods of using the same to increase EPA uptake in tissues to treat and/or prevent the onset of a number of diseases including:

- Cardiopulmonary, cardiovascular, and cerebrovascular diseases
- Pulmonary disease including sepsis, SIRS, and/or ARDS
- Neurological diseases
- Cancer
- Diseases associated with the kidneys, pancreas, liver, intestines, blood cells, lymph, and the musculoskeletal system
- Diseases associated with oxidative stress and/or glutathione (GSH) depletion
- Inflammation and diseases induced by air pollution
ETC......."